Global Cervical Total Disc Replacement Device Market: Key Developments
On February 14, 2023, Centinel Spine, LLC, a privately-held spine company focused on anterior column reconstruction, announced the completion of the 500th procedure in the U.S. with its latest US FDA-approved total disc replacement (TDR) system of prodisc cervical solutions, prodisc C Vivo, and prodisc C SK. The keel-less prodisc C Vivo device offers a combination of a well-designed anatomical endplate shape along with robust spikes that provide strong immediate fixation.
On January 30, 2023, ZimVie Inc., one of the global life sciences leaders in the dental and spine markets, announced that over 200,000 Mobi-C Cervical Discs have been implanted worldwide. Since the device's first operation was done in France in 2004, this comprises patients who have been treated in more than 25 nations. The U.S. Food and Drug Administration granted Mobi-C clearance as the first cervical disc in 2013 to treat several levels of the cervical spine.
In November 2019, Orthofix Medical Inc., one of the leading medical device company and provider of spinal, orthopedic, bone growth, and motion preservation products received the U.S. Food and Drug Administration approval for its M6-C artificial cervical disc for patients with cervical disc degeneration. The device was originally developed by Spinal Kinetics; however, Spinal Kinetics was acquired by Orthofix in March 2018.
In March 2019, AxioMed LLC, a medical device company specialized in the development of spine technology for fusion and first-generation artificial discs, received the Conformité Européenne (CE) mark for its Cervical Freedom Total Disc Replacement, a viscoelastic disc replacement device.
Global Cervical Total Disc Replacement Device Market: Key Trends
Increasing research and development activities
Increasing research and development activities is expected to drive the market growth over the forecast period. For instance, on January 6, 2023, The Disc Replacement Center along with Mr. Armen Khachatryan (MD), Doctor of Medicine and a skilled provider specializing in Orthopedic Surgery near West Jordan UTannounced the successful completion of the first series of MOTUS lumbar total joint replacement surgeries as part of the BalancedBack pivotal clinical trial sponsored by 3Spine, Inc., a private, clinical phase healthcare company. In a second prospective 3Spine research, patients who underwent a standard spinal fusion were compared to patients who underwent the innovative low back complete joint surgery to see how they fared. At the Global Microsurgical Center of Park City, Dr. Khachatryan finished the initial set of MOTUS operations. In the following months, he will accept a small number of additional patients from the wider Salt Lake City region.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients